News
James Brady Joins Verona Pharma as Non-Executive Director
LONDON and RALEIGH, N.C., March 14, 2022 (GLOBE NEWSWIRE) --…
Versameb CEO Klaas Zuideveld to Present at the RNA Leaders World Congress
Presentation demonstrates lead therapeutic candidate VMB-100…
Exact Therapeutics Announces Clinical Trial Update
OSLO/LONDON, 08 March 2022: EXACT THERAPEUTICS AS (“EXACT-Tx”,…
Destiny Pharma Fundraising to raise up to £7.0 million
Destiny Pharma plc (AIM: DEST) (the “Company” or “Destiny…
Neuraxpharm expands its business in Southeast Europe
Acquisition of Brain Therapeutics with operations in Greece, Cyprus…
Verona Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Phase 3 ENHANCE program on track to report top-line COPD data…
Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie
March 1, 2022
Deal value of US$ 1 billion with…
Touchlight and Versameb announce GMP manufacturing supply agreement
Versameb moves forward with its lead asset towards clinical…
ISA Pharmaceuticals long term study confirms efficacy of our T-cell activating immunotherapy in combination with checkpoint inhibitor
Data published in the Journal of ImmunoTherapy of Cancer confirms…
Novo Holdings continues to back Biomason by participating in its US$65M Series C Financing
Funds will accelerate wide-scale adoption and commercialisation…
Egetis Therapeutics asks for hugs to increase disease awareness of MCT8 deficiency
February 24, 2022
Stockholm, Sweden, February 24, 2022 –…
Versameb appoints world leading experts in urology to Advisory Board
Appointment of experts to support development of lead candidate…
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScanTM (Kit for the Preparation of Technetium Tc 99m Succimer Injection)
NephroScan is now US FDA approved for the preparation of Tc-99m…
Study indicates that AMSilk engineered silk implant coatings can prevent infection
Repellence properties of silk coatings reduced microbial…
TargED raises €39 million in a series A investment round
TargED is extremely pleased and proud to have raised €39 million…
ISA Pharmaceuticals to Attend Multiple In Person Conferences in Early 2022
Oegstgeest, the Netherlands, February 17, 2022 – ISA Pharmaceuticals…
Versameb to present at the Female Pelvic Medicine and Urogenital Reconstruction 2022 Winter Meeting
Data demonstrates first-in-class potential as a regenerative…
Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform
Curve’s innovative mammalian cell drug discovery platform…
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
Financing co-led by UCB Ventures and Ysios Capital…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York
